TY  - GEN
AU  - La Rosa,Corinna
AU  - Longmate,Jeff
AU  - Lacey,Simon F
AU  - Kaltcheva,Teodora
AU  - Sharan,Rahul
AU  - Marsano,Denise
AU  - Kwon,Peter
AU  - Drake,Jennifer
AU  - Williams,Brenda
AU  - Denison,Sharon
AU  - Broyer,Suenell
AU  - Couture,Larry
AU  - Nakamura,Ryotaro
AU  - Dadwal,Sanjeet
AU  - Kelsey,Morris I
AU  - Krieg,Arthur M
AU  - Diamond,Don J
AU  - Zaia,John A
TI  - Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant
SN  - 1537-6613
PY  - 2012///0521
KW  - Adjuvants, Immunologic
KW  - administration & dosage
KW  - Adolescent
KW  - Adult
KW  - Amino Acid Sequence
KW  - CD8-Positive T-Lymphocytes
KW  - physiology
KW  - Cytomegalovirus Infections
KW  - prevention & control
KW  - Cytomegalovirus Vaccines
KW  - Dose-Response Relationship, Immunologic
KW  - Epitopes
KW  - Female
KW  - Humans
KW  - Malaria Vaccines
KW  - immunology
KW  - Male
KW  - Middle Aged
KW  - Oligodeoxyribonucleotides
KW  - Recombinant Proteins
KW  - Tetanus Toxoid
KW  - Vaccines, Synthetic
KW  - Young Adult
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/infdis/jis107
ER  -